Drug Target Review

DECEMBER 20, 2024

Artificial intelligence (AI) has revolutionised many industries, yet its adoption in pharmaceutical drug development has been notably slower. Concerns surrounding data security, the complexity of AI systems, and the rigorous regulatory frameworks in this field have caused the pharmaceutical industry to approach these technologies with caution. For years, AI and machine learning (ML) were often dismissed as little more than advanced statistics with little practical value in drug development.

Clinical Trials

Perficient: Drug Development

DECEMBER 19, 2024

Welcome to our ongoing series on Universal Design for Healthcare! In this segment, well explore the importance of Visual Disabilities in Healthcare. Creating an inclusive healthcare environment for individuals with complete blindness is a fundamental aspect of universal design. These individuals rely heavily on non-visual cues to navigate, access information, and communicate effectively.

Hospitals

BMG Labtech

DECEMBER 20, 2024

Bacterial metabolism applications Bacterial metabolism spans the complex interconnected set of chemical reactions that support life in bacteria, ancient single-celled organisms that represent one of the most diverse forms of life on Earth. Bacterial metabolism is the foundation for bacterial growth and is inextricably linked to other organisms in the ecosystem.

Regulations

PPD

DECEMBER 16, 2024

Our annual look at the state of the drug development industry highlights a dual set of challenges complicating progress. The drug development industry faces rising costs and increasingly complex protocols as top challenges, with 49% of developers citing costs as their primary concern and 39% pointing to protocol complexity as a key hurdle, according to a recent survey of 150 drug developers worldwide by the PPD clinical research business of Thermo Fisher Scientific.

Drug Development

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Clinical Trials

Drug Target Review

DECEMBER 16, 2024

Dr Pooja Hingorani, Senior Medical Director of Oncology Early Development at AbbVie , shares her journey in STEM, from her early days in New Delhi to her impactful career in oncology research and drug development. Despite challenges as a woman in the field, Dr Hingorani built a career focused on advancing treatments for pediatric and adult cancers. In this interview, she discusses her path to becoming a physician and clinical researcher, the obstacles she faced, and her dedication to improving o

Medical Schools

Perficient: Drug Development

DECEMBER 18, 2024

Welcome to our ongoing series on Universal Design for Healthcare! In this segment, well explore the importance of Visual Disabilities in Healthcare. Effective communication is vital in healthcare, and ensuring that it is accessible to individuals with visual disabilities is an essential aspect of universal design. Clear and accessible communication methods help patients understand their health information, engage with their care, and make informed decisions.

Treatment

The Premier Consulting Blog

DECEMBER 16, 2024

New drug development is a long and expensive process that can be fraught with obstacles, including unexpected delays, poor efficacy results, safety issues, or regulatory challenges. Pharmaceutical companies may, at times, find themselves at an impasse during development, facing weighty decisions about whether to slow down or hit the brakes on a development program.

Pharmacokinetics

Drug Target Review

DECEMBER 16, 2024

Since their first approvals in 2017, autologous CAR T-cell therapies have revolutionised the treatment of blood cancers, offering hope where previous options had failed. However, in their current ex vivo form, a patients cells are collected and then modified over weeks or months in a distant manufacturing site. Consequently, these therapies come with significant burdens and are often underutilised despite their transformative patient outcomes.

Therapies

ACTO

DECEMBER 17, 2024

Part 2 Our first blog covered the ABCs of Artificial Intelligence (AI) and AIs evolution. This post discusses key issues pharma executives must consider to ensure responsible, compliant, and successful AI implementation within their organizations. The stakes for AI adoption in the pharmaceutical industry have never been higher. A survey of healthcare and life science companies found that 93% of these companies expect to increase their spend in 2025.

Government

Drug Patent Watch

DECEMBER 16, 2024

When it comes to researching and navigating the complex world of drug patents, inventors and researchers often turn to various tools to find relevant information. Google Patents, with its user-friendly interface and vast database, might seem like an ideal resource. However, there are several reasons why relying solely on Google Patents can be risky, especially in the context of pharmaceutical patents.

Drugs

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Treatment

Advarra

DECEMBER 17, 2024

2024 has been a year of growth and evolution in clinical research. The coming year is expected to be no different. As we look to 2025, Advarra thought leaders have compiled predictions and perspectives on key topics shaping the industry. These topics include perspectives on how artificial intelligence (AI) will be leveraged in clinical research, key regulatory trends shaping the industry, the movements of site consolidation, the continued challenges (and potential solutions) of study startup, an

Clinical Research

Covalent Modifiers

DECEMBER 20, 2024

Joseph E Klebba, Nilotpal Roy, Steffen M Bernard, Stephanie Grabow, Melissa A. Hoffman, Hui Miao, Junko Tamiya, Jinwei Wang, Cynthia Berry, Antonio Esparza-Oros, Richard Lin, Yongsheng Liu, Marie Pariollaud, Holly Parker, Igor Mochalkin, Sareena Rana, Aaron N. Snead, Eric J. Walton, Taylor E. Wyrick, Erick Aitichson, Karl Bedke, Jacyln C. Brannon, Joel M.

Conversations in Drug Development Trends

DECEMBER 19, 2024

At the recent World Orphan Drug Congresses (WODC) in Europe and the United States, Worldwide Clinical Trials Derek Ansel , Vice President, Therapeutic Strategy Lead, Rare Disease, facilitated roundtable discussions to explore the operational challenges and ethical barriers surrounding genetic testing. While the agenda remained the same across both events, the conversations revealed key regional distinctions and global perspectives on how genetic testing, ethics, and operational challenges are ad

Clinical Trials

Perficient: Drug Development

DECEMBER 18, 2024

In the world of modern web development, enhancing user experience is a top priority. One of the most popular features for improving searchability is the “Typeahead” functionality, which provides dynamic suggestions as users type. This feature can significantly speed up data entry, reduce errors, and make your application feel more responsive.

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

BMG Labtech

DECEMBER 20, 2024

Absorbance measurements, often referred to as light absorbance, are so versatile and widespread that they are one of the first techniques many life science researchers encounter in a practical setting. Absorbance measurements are taken at a particular wavelength to determine the amount of light absorbed by a substance. Optical density is also widely used for many scientific applications.

DNA

Drug Patent Watch

DECEMBER 18, 2024

Protecting your intellectual property is paramount. Drug patent prosecution is a complex and critical process that can make or break the success of a new medication. As a business professional in the pharmaceutical industry, understanding and implementing effective strategies for drug patent prosecution can be the difference between market domination and missed opportunities.

Pharmaceuticals

FDA Law Blog: Drug Discovery

DECEMBER 15, 2024

By Richard A. Lewis, Senior Regulatory Device & Biologics Expert & James E. Valentine We recently published the first part of our review of FDAs draft guidance titled Frequently Asked Questions Developing Potential Cellular and Gene Therapy Products. Questions and Answers Guidance (see previous coverage here ). In this post we focus in on the draft guidance documents chemistry, manufacturing, and controls (CMC)-specific content.

Therapies

Perficient: Drug Development

DECEMBER 16, 2024

Welcome to our ongoing series on Universal Design for Healthcare! In this segment, well explore the importance of Visual Disabilities in Healthcare. Ensuring that healthcare facilities are physically accessible to individuals with visual disabilities is a key aspect of universal design. An accessible physical environment helps patients navigate spaces safely and independently, fostering a more inclusive and supportive healthcare experience.

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Clinical Trials

Science Daily: Pharmacology News

DECEMBER 19, 2024

Fossilized skeletons and shells clearly show how evolution and extinction unfolded over the past half a billion years, but a new analysis extends the chart of life to nearly 2 billion years ago. The chart shows the relative ups and downs in species counts, telling scientists about the origin, diversification, and extinction of ancient life. With this new study, the chart of life now includes life forms from the Proterozoic Eon, 2,500 million to 539 million years ago.

Drug Channels

DECEMBER 17, 2024

Happy New Year, everyone! Its been a huge year for Drug Channels Institute (DCI). In January, HMP Global acquired DCI. Thanks to our new friends at HMP, we will hold the Drug Channels Leadership Forum. This landmark event will take place in March 2025 in Miami. (If you havent done so yet, click here to request an invitation.) Once again, I thank you, dear readers, for welcoming Drug Channels into your inboxes, browsers, and apps.

Pharmacy

BioPharma Drive: Drug Pricing

DECEMBER 20, 2024

Novo shares lost nearly a quarter of their value after an experimental combination treatment called cagrisema fell short of the bar set by executives.

Trials

Perficient: Drug Development

DECEMBER 19, 2024

When you’re running Selenium tests in Python, particularly in large projects, the ability to generate detailed and readable reports is essential for understanding test results, tracking failures, and improving overall test management. In this blog post, we’ll explore how to integrate reporting into your Selenium tests using Pytest , one of the most popular testing frameworks for Python.

Packaging

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Clinical Trials

Science Daily: Pharmacology News

DECEMBER 20, 2024

Physician-scientists found that a subset of artificial heart patients can regenerate heart muscle, which may open the door to new ways to treat and perhaps someday cure heart failure.

Drugs.com

DECEMBER 20, 2024

FRIDAY, Dec. 20, 2024 -- An existing drug might be able to treat an autoimmune disorder that causes dry eye, dry mouth, fatigue and muscle or joint pain. Baricitinib (Olumiant), a drug currently used to treat rheumatoid arthritis, appears to.

Disease

BioPharma Drive: Drug Pricing

DECEMBER 19, 2024

The FDA’s decision will close a lucrative market opportunity for compounding pharmacies, although the agency will give a limited grace period before taking any enforcement actions.

Compounding Pharmacies

Perficient: Drug Development

DECEMBER 19, 2024

Welcome to our ongoing series on Universal Design for Healthcare! In this segment, well explore the importance of Visual Disabilities in Healthcare. Color vision deficiency (CVD), often referred to as color blindness, affects an individual’s ability to distinguish certain colors. This can create unique challenges in healthcare settings, where color-coded information is commonly used.

Medical Schools

Science Daily: Pharmacology News

DECEMBER 18, 2024

California ground squirrels hunt, kill and eat voles, reveals a new study documenting evidence of widespread carnivorous behavior among squirrels.

Drugs.com

DECEMBER 16, 2024

MONDAY, Dec. 16, 2024 -- The established hormone therapy drug tamoxifen can significantly decrease the risk of cancer recurring in women with an early, low-risk form of breast cancer, a new study says. Women who took tamoxifen after undergoing a.

Therapies

BioPharma Drive: Drug Pricing

DECEMBER 16, 2024

The company is scrapping two drugs aimed at targets called TIGIT and LAG-3, both of which were in the middle of Phase 3 testing.

Drugs

Perficient: Drug Development

DECEMBER 18, 2024

Building GitLab CI/CD Pipelines with AWS Integration GitLab CI/CD (Continuous Integration/Continuous Deployment) is a powerful, integrated toolset within GitLab that automates the software development lifecycle (SDLC). It simplifies the process of building, testing, and deploying code, enabling teams to deliver high-quality software faster and more efficiently.

Production

Science Daily: Pharmacology News

DECEMBER 18, 2024

A research team has taken a crucial step towards resolving a long-standing controversy -- was syphilis introduced to Europe from the Americas at the end of the 15th century, or had it been there all along? Ancient pathogen genomes from skeletons that pre-date 1492 confirm its introduction from the Americas, but its world-wide spread remains a grim legacy of the colonial period.

Research

Drugs.com

DECEMBER 20, 2024

FRIDAY, Dec. 20, 2024 -- An outbreak of salmonella linked to cucumbers has now been tied to 100 known cases of the illness across 23 states, the U.S. Food and Drug Administration reported Thursday. That's up from 68 cases reported in the FDA's last.

FDA